Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Hoenigl

Showing results (11-20 of 353) with videos related to

Pageof 36
Sort By:
Expert Review of Molecular Diagnostics|August 20, 2016
How can we detect HIV during the acute or primary stage of infection?Martin Hoenigl, Susan J Little
Expert Review of Molecular Diagnostics|September 9, 2020
Point-of-care diagnostics for invasive aspergillosis: nearing the finish lineJeffrey D Jenks, Martin Hoenigl
Journal of Fungi (Basel, Switzerland)|August 22, 2018
Treatment of AspergillosisJeffrey D Jenks, Martin Hoenigl
The Journal of Infectious Diseases|May 29, 2019
Salvage Antiretroviral Therapy: Time for "DeNUKElearization"?Martin Hoenigl, Susan J Little
Journal of Laboratory and Precision Medicine|September 1, 2018
CD4:CD8 ratio and CD8+ cell count for prognosticating mortality in HIV-infected patients on antiretroviral therapyJeffrey Daniel Jenks, Martin Hoenigl
Antimicrobial Agents and Chemotherapy|June 22, 2016
Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State LevelsJürgen Prattes, Wiebke Duettmann, Martin Hoenigl
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 14, 2025
Association between allergic bronchopulmonary aspergillosis or Aspergillus sensitization and tuberculosis: A systematic review of 607 casesAnuj Ajayababu, Martin Hoenigl, Animesh Ray
Intensive Care Medicine|September 1, 2021
COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challengesJuergen Prattes, Philipp Koehler, Martin Hoenigl, et al.
Infectious Disease Clinics of North America|December 19, 2024
Climate Change and Medical MycologySarah Sedik, Matthias Egger, Martin Hoenigl
Expert Review of Clinical Pharmacology|February 21, 2024
Therapeutic drug monitoring of antifungal therapies: do we really need it and what are the best practices?Johannes Boyer, Martin Hoenigl, Lisa Kriegl
Pageof 36

Showing results (11-20 of 353) with videos related to

Sort By:
Pageof 36
Expert Review of Molecular Diagnostics|August 20, 2016
How can we detect HIV during the acute or primary stage of infection?Martin Hoenigl, Susan J Little
Expert Review of Molecular Diagnostics|September 9, 2020
Point-of-care diagnostics for invasive aspergillosis: nearing the finish lineJeffrey D Jenks, Martin Hoenigl
Journal of Fungi (Basel, Switzerland)|August 22, 2018
Treatment of AspergillosisJeffrey D Jenks, Martin Hoenigl
The Journal of Infectious Diseases|May 29, 2019
Salvage Antiretroviral Therapy: Time for "DeNUKElearization"?Martin Hoenigl, Susan J Little
Journal of Laboratory and Precision Medicine|September 1, 2018
CD4:CD8 ratio and CD8+ cell count for prognosticating mortality in HIV-infected patients on antiretroviral therapyJeffrey Daniel Jenks, Martin Hoenigl
Antimicrobial Agents and Chemotherapy|June 22, 2016
Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State LevelsJürgen Prattes, Wiebke Duettmann, Martin Hoenigl
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 14, 2025
Association between allergic bronchopulmonary aspergillosis or Aspergillus sensitization and tuberculosis: A systematic review of 607 casesAnuj Ajayababu, Martin Hoenigl, Animesh Ray
Intensive Care Medicine|September 1, 2021
COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challengesJuergen Prattes, Philipp Koehler, Martin Hoenigl, et al.
Infectious Disease Clinics of North America|December 19, 2024
Climate Change and Medical MycologySarah Sedik, Matthias Egger, Martin Hoenigl
Expert Review of Clinical Pharmacology|February 21, 2024
Therapeutic drug monitoring of antifungal therapies: do we really need it and what are the best practices?Johannes Boyer, Martin Hoenigl, Lisa Kriegl
Pageof 36